| scholarly article | Q13442814 |
| P50 | author | Jacques Pouysségur | Q33104019 |
| P2093 | author name string | D Roux | |
| I Peyrottes | |||
| J Doyen | |||
| J M Ferrero | |||
| J Gal | |||
| S K Parks | |||
| F Ettore | |||
| C Trastour | |||
| K Ilc | |||
| N Toussant | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 54-61 | |
| P577 | publication date | 2014-07-21 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome. | |
| P478 | volume | 451 |
| Q35828452 | AMP-activated protein kinase is dispensable for maintaining ATP levels and for survival following inhibition of glycolysis, but promotes tumour engraftment of Ras-transformed fibroblasts |
| Q35575632 | Acidic microenvironment and bone pain in cancer-colonized bone |
| Q91650469 | CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy |
| Q50034271 | Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness. |
| Q49564212 | Composite analysis of immunological and metabolic markers defines novel subtypes of triple negative breast cancer |
| Q28085753 | Contribution of acidic extracellular microenvironment of cancer-colonized bone to bone pain |
| Q47836759 | Deciphering metabolic rewiring in breast cancer subtypes |
| Q92201027 | Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma |
| Q51632004 | Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival. |
| Q28081811 | Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters |
| Q37564738 | Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas |
| Q38791887 | Inhibition of monocarboxylate transporter 1 suppresses the proliferation of glioblastoma stem cells |
| Q38849618 | Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells. |
| Q38704738 | Involvement of ion channels and transporters in carcinoma angiogenesis and metastasis. |
| Q36413000 | Knock out of the BASIGIN/CD147 chaperone of lactate/H+ symporters disproves its pro-tumour action via extracellular matrix metalloproteases (MMPs) induction |
| Q91649922 | Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy |
| Q37091959 | Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness |
| Q91974693 | Metabolic reprogramming in triple-negative breast cancer |
| Q47100203 | Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer |
| Q58698489 | Monocarboxylate Transporter 4 (MCT4) Knockout Mice Have Attenuated 4NQO Induced Carcinogenesis; A Role for MCT4 in Driving Oral Squamous Cell Cancer |
| Q92608516 | Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma |
| Q97646407 | Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference |
| Q92506650 | Monocarboxylate transporters in cancer |
| Q26749333 | Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction |
| Q26771312 | Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis |
| Q26749393 | Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis |
| Q98386338 | Prognostic and predictive value of monocarboxylate transporter 4 in patients with breast cancer |
| Q92468996 | Proliferating tumor cells mimick glucose metabolism of mature human erythrocytes |
| Q26781245 | Research into cancer metabolomics: Towards a clinical metamorphosis |
| Q92242813 | Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance |
| Q61135172 | Systems analysis of intracellular pH vulnerabilities for cancer therapy |
| Q36910309 | Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy |
| Q36326353 | Targeting lactate transport suppresses in vivo breast tumour growth |
| Q38917545 | The Na(+)/HCO3(-) Co-Transporter SLC4A4 Plays a Role in Growth and Migration of Colon and Breast Cancer Cells |
| Q28072360 | The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters |
| Q55046277 | The clinicopathological significance of monocarboxylate transporters in testicular germ cell tumors. |
Search more.